To be sure, over the years, a handful of companies have taken potshots at Roche Molecular Systems Inc. , the molecular diagnostics subsidiary of Roche . But RMS maintains a powerful presence, with more than 70% share of a roughly $700 million market.
Now, two of the biggest IVD companies are positioning themselves to go head-to-head with the market leader. Abbott Laboratories Inc....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?